Company Filing History:
Years Active: 2010
Title: Yann Griffon: Innovator in Therapeutic Compounds
Introduction
Yann Griffon is a notable inventor based in Essex, GB. He has made significant contributions to the field of therapeutic compounds, particularly in the treatment of inflammatory conditions. His innovative work has led to the development of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Yann Griffon holds a patent for "Quinolines and their therapeutic use." This patent describes compounds of formula [1] that act as CRTH2 antagonists, which are useful in treating conditions with inflammatory components. The patent details various substituents and functional groups that enhance the therapeutic potential of these compounds.
Career Highlights
Throughout his career, Yann has worked with several companies, including Pulmagen Therapeutics Limited and Pulmagen Therapeutics (Asthma) Limited. His experience in these organizations has allowed him to focus on developing innovative solutions for asthma and other respiratory conditions.
Collaborations
Yann has collaborated with notable professionals in his field, including Michael Colin Cramp and Rosa Arienzo. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Yann Griffon's work exemplifies the impact of innovation in the medical field. His patent for quinolines highlights his commitment to improving therapeutic options for patients with inflammatory conditions. His contributions continue to inspire future advancements in medical research.